Article

Tanz, Lauren J and Gladden, R Matt and Dinwiddie, Amanda T and Miller, Kimberly D and Broz, Dita and Spector, Eliot and O’Donnell, Julie (2024) Routes of drug use among drug overdose deaths — United States, 2020–2022. Morbidity and Mortality Weekly Report , 73 , pp. 124-130.

Minozzi, Silvia and Saulle, Rosella and Amato, Laura and Traccis, Francesco and Agabio, Roberta (2024) Psychosocial interventions for stimulant use disorder. Cochrane Database of Systematic Reviews , 2 , (2) .

Casillas, Shannon M and Pickens, Cassandra M and Tanz, Lauren J and Vivolo-Kantor, Alana M (2024) Estimating the ratio of fatal to non-fatal overdoses involving all drugs, all opioids, synthetic opioids, heroin or stimulants, USA, 2010-2020. Injury Prevention , 30 , (2) , pp. 114-124.

Devin, Joan and Lyons, Suzi and Murphy, Lisa and O'Sullivan, Michael and Lynn, Ena (2023) Factors associated with suicide in people who use drugs: a scoping review. BMC Psychiatry , 23 .

Dangore-Khasbage, Suwarna and Bhowate, Rahul R and Khubchandani, Monika (2023) Chemical composition of areca nut and its adverse effects on human health. Cureus , 15 , (8) .

McCabe, Sean Esteban and Schulenberg, John E and Wilens, Timothy E and Schepis, Ty S and McCabe, Vita V and Veliz, Phil T (2023) Cocaine or methamphetamine use during young adulthood following stimulant use for attention-deficit/hyperactivity disorder during adolescence. JAMA Network Open , 6 , (7) .

Ciucă Anghel, Daniela-Mădălina and Nițescu, Gabriela Viorela and Tiron, Andreea-Taisia and Guțu, Claudia Maria and Baconi, Daniela Luiza (2023) Understanding the mechanisms of action and effects of drugs of abuse. Molecules , 28 , (13) .

Cui, Zishan and Karamouzian, Mohammad and Law, Michael and Hayashi, Kanna and Milloy, M-J and Kerr, Thomas (2023) The impact of longitudinal substance use patterns on the risk of opioid agonist therapy discontinuation: a repeated measures latent class analysis. International Journal of Mental Health and Addiction , Early online .

Toigo, Stephanie and McFaull, Steven R and Thompson, Wendy (2023) Impact of substance-related harms on injury hospitalizations in Canada, from 2010 to 2020. Health Promotion and Chronic Disease Prevention in Canada , 43 , (3) , pp. 130-138.

Kim, Soyeon and Weekes, John and Young, Matthew M and Adams, Nicole and Kolla, Nathan J (2023) Trends of repeated emergency department visits among adolescents and young adults for substance use: a repeated cross-sectional study. PLoS ONE , 18 , (2) .

Di Paola, Angela and Farabee, David and Springer, Sandra A (2023) Validation of two diagnostic assessments for opioid and stimulant use disorder for use by non‐clinicians. Psychiatric Research & Clinical Practice , 5 , (3) , pp. 78-83.

Palis, Heather and Gan, Wenqi and Xavier, Chloe and Desai, Roshni and Scow, Marnie and Sedgemore, Kali-Olt and Greiner, Leigh and Nicholls, Tonia and Slaunwhite, Amanda (2022) Association of opioid and stimulant use disorder diagnoses with fatal and nonfatal overdose among people with a history of incarceration. JAMA Network Open , 5 , (11) .

Mintz, Carrie M and Xu, Kevin Y and Presnall, Ned J and Hartz, Sarah M and Levin, Frances R and Scherrer, Jeffrey F and Bierut, Laura J and Grucza, Richard A (2022) Analysis of stimulant prescriptions and drug-related poisoning risk among persons receiving buprenorphine treatment for opioid use disorder. JAMA Network Open , 5 , (5) .

Millar, Sean (2022) Drug use among students in higher education in Ireland. Drugnet Ireland , Issue 81, Spring 2022 , pp. 1-4.

Liebregts, Nienke and Rigoni, Rafaela and Petruželka, Benjamin and Barták, Miroslav and Rowicka, Magdalena and Zurhold, Heike and Schiffer, Katrin (2022) Different phases of ATS use call for different interventions: a large qualitative study in Europe. Harm Reduction Journal , 19 .

Karamouzian, Mohammad and Pilarinos, Andreas and Hayashi, Kanna and Buxton, Jane A and Kerr, Thomas (2022) Latent patterns of polysubstance use among people who use opioids: a systematic review. International Journal of Drug Policy , 102 , p. 103584.

Carolan, Deirdre (2022) ADHD stimulant medication misuse and considerations for current prescribing practice: a literature review. Irish Journal of Medical Science , 191 , (1) , pp. 313-320.

Turner, Daniel and Briken, Peer and Grubbs, Joshua and Malandain, Leo and Mestre-Bach, Gemma and Potenza, Marc N and Thibaut, Florence (2022) The World Federation of Societies of Biological Psychiatry guidelines on the assessment and pharmacological treatment of compulsive sexual behaviour disorder. Dialogues in Clinical Neuroscience , 24 , (1) , pp. 10-69.

Millar, Sean (2021) Relationships between cannabis and recent use of stimulant drugs. Drugnet Ireland , Issue 79, Autumn 2021 , pp. 21-22.

Ellis, Matthew S and Kasper, Zachary A and Scroggins, Stephen (2021) Shifting pathways of stimulant use among individuals with opioid use disorder: a retrospective analysis of the last thirty years. Frontiers in Psychiatry , 12 , p. 786056.

Tadrous, Mina and Shakeri, Ahmad and Chu, Cherry and Watt, Jennifer and Mamdani, Muhammad M and Juurlink, David N and Gomes, Tara (2021) Assessment of stimulant use and cardiovascular event risks among older adults. JAMA Network Open , 4 , (10) , e2130795.

Docherty, James R and Alsufyani, Hadeel A (2021) Cardiovascular and temperature adverse actions of stimulants. British Journal of Pharmacology , 178 , (13) , pp. 2551-2568.

Millar, Seán and Mongan, Deirdre and O'Dwyer, Claire and Smyth, Bobby P and Perry, Ivan J and Galvin, Brian (2021) Relationships between patterns of cannabis use, abuse and dependence and recent stimulant use: evidence from two national surveys in Ireland. PLoS ONE , 16 , (8) .

Jonovska, Suzana and Sugnet, Tom and Šendula-Jengić, Vesna (2021) High-dose methylphenidate use prior to hospitalization exacerbates the withdrawal syndrome in inpatients treated for opioid and sedative-hypnotic co-dependence - case series and review of the literature. Psychiatria Danubina , 33 , (Suppl 4) , pp. 1240-1242.

Moyle, Leah and Dymock, Alex and Aldridge, Alexandra and Mechen, Ben (2020) Pharmacosex: reimagining sex, drugs and enhancement. International Journal of Drug Policy , 86 .

Crabtree, Alexis and Lostchuck, Emily and Chong, Mei and Shapiro, Aaron and Slaunwhite, Amanda Kathleen (2020) Toxicology and prescribed medication histories among people experiencing fatal illicit drug overdose in British Columbia, Canada. CMAJ , 192 , (34) .

Martens, Marcus-Sebastian and Zurhold, Heike and Rosenkranz, Moritz and O'Donnell, Amy and Addison, Michelle and Spencer, Liam and McGovern, William and Gabrhelík, Roman and Petruželka, Benjamin and Rowicka, Magdalena and Liebregts, Nienke and Degkwitz, Peter and Kaner, Eileen and Verthein, Uwe (2020) Using life course charts to assess and compare trajectories of amphetamine type stimulant consumption in different user groups: a cross-sectional study. Harm Reduction Journal , 17 , (1) , p. 8.

Fleming, Taylor and Barker, Allison and Ivsins, Andrew and Vakharia, Sheila and McNeil, Ryan (2020) Stimulant safe supply: a potential opportunity to respond to the overdose epidemic. Harm Reduction Journal , 17 , (6) .

Hoots, Brooke and Vivolo-Kantor, Alana and Seth, Puja (2020) The rise in non-fatal and fatal overdoses involving stimulants with and without opioids in the United States. Addiction , 115 , (5) .

Ronsley, Claire and Nolan, Seonaid and Knight, Rod and Hayashi, Kanna and Klimas, Jano and Walley, Alex and Wood, Evan and Fairbairn, Nadia (2020) Treatment of stimulant use disorder: a systematic review of reviews. PLoS ONE , 15 , (6) .

Livingstone-Banks, Jonathan (2019) Clinical question: Can psychosocial interventions, given alone or added to treatment as usual, improve outcomes for people who misuse psychostimulants? Cochrane Clinical Answers .

Gibbs, Daisy and Hughes, Caitlin and Barrett, Monica and Ezard, Nadine and Bruno, Raimondo and Sutherland, Rachel and Grigg, Jodie and Salom, Caroline and Hill, Penny and Dietze, Paul and Lenton, Simon R and Degenhardt, Louisa and Peacock, Amy (2019) Illicit drug use and awareness of health and policing initiatives at Australian music festivals among people who regularly use ecstasy and other illicit stimulants. Drug Trends Bulletin Series .

Harada, Takayuki and Tsutomi, Hiroshi and Mori, Rintaro and Wilson, David B (2018) Cognitive‐behavioural treatment for amphetamine‐type stimulants (ATS)‐use disorders. Cochrane Database of Systematic Reviews , (12) .

Lucke, Jayne and Jensen, Charmaine and Dunn, Matthew and Chan, Gary and Forlini, Cynthia and Kaye, Sharlene and Partridge, Bradley and Farrell, Michael and Racine, Eric and Hall, Wayne (2018) Non-medical prescription stimulant use to improve academic performance among Australian university students: prevalence and correlates of use. BMC Public Health , 18 , (1) , p. 1270.

Marel, Christina and Sunderland, Matthew and Mills, Katherine L and Slade, Tim and Teesson, Maree and Chapman, Cath (2018) Conditional probabilities of substance use disorders and associated risk factors: Progression from first use to use disorder on alcohol, cannabis, stimulants, sedatives and opioids. Drug and Alcohol Dependence , 194 .

Burch, Jane and Kavirajan, Harish (2018) Clinical question: What are the benefits and harms of psychostimulant drugs for people with cocaine dependence? Cochrane Clinical Answers .

Frankis, Jamie and Flowers, Paul and McDaid, Lisa and Bourne, Adam (2018) Low levels of chemsex among men who have sex with men, but high levels of risk among men who engage in chemsex: analysis of a cross-sectional online survey across four countries. Sexual Health , 15 , (2) , pp. 144-150.

Lauritzen, Grethe and Nordfjærn, Trond (2018) Changes in opiate and stimulant use through 10 years: the role of contextual factors, mental health disorders and psychosocial factors in a prospective SUD treatment cohort study. PLoS ONE , 13 , (1) , e0190381.

Peacock, Amy and Leung, Janni and Larney, Sarah and Colledge, Samantha and Hickman, Matthew and Rehm, Jürgen and Giovino, Gary A and West, Robert and Hall, Wayne and Griffiths, Paul and Ali, Robert and Gowing, Linda and Marsden, John and Ferrari, Alize J and Grebely, Jason and Farrell, Michael and Degenhardt, Louisa (2018) Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction , 113 , (10) .

Glynn, Ronan W and Byrne, Niamh and O'Dea, Siobhan and Shanley, Adam and Codd, Mary and Keenan, Eamon and Ward, Mary and Igoe, Derval and Clarke, Susan (2017) Chemsex, risk behaviours and sexually transmitted infections among men who have sex with men in Dublin, Ireland. International Journal of Drug Policy , 52 , pp. 9-15.

Enns, Benjamin and Krebs, Emanuel and DeBeck, Kora and Hayashi, Kanna and Milloy, M-J and Richardson, Lindsey and Wood, Evan and Nosyk, Bohdan (2017) The costs of crime associated with stimulant use in a Canadian setting. Drug and Alcohol Dependence , 180 , pp. 304-310.

Abelman, Dor David (2017) Mitigating risks of students use of study drugs through understanding motivations for use and applying harm reduction theory: a literature review. Harm Reduction Journal , 14 , (1) , p. 68.

O’Brien Green, Siobhan (2017) Club Health 2017 conference to be held in Dublin. Drugnet Ireland , Issue 60, Winter 2017 , p. 24.

McLaughlin, Gavin and Morris, Noreen and Kavanagh, Pierce V and Power, John D and Dowling, Geraldine and Twamley, Brendan and O'Brien, John and Hessman, Gary and Murphy, Brian and Walther, Donna and Partilla, John S and Baumann, Michael H and Brandt, Simon D (2017) Analytical characterization and pharmacological evaluation of the new psychoactive substance 4-fluoromethylphenidate (4F-MPH) and differentiation between the (±)-threo and (±)-erythro diastereomers. Drug Testing and Analysis , 9 , (3) , pp. 347-357.

Minozzi, Silvia and Saulle, Rosella and De Crescenzo, Franco and Amato, Laura (2016) Psychosocial interventions for psychostimulant misuse. Cochrane Database of Systematic Reviews , (9) .

Galvin, Brian (2016) European drug trends 2016. Drugnet Ireland , Issue 58, Summer 2016 , pp. 12-13.

Pike, Brigid (2016) Terminology and information on drugs. Drugnet Ireland , Issue 57, Spring 2016 , p. 13.

Hearne, Evelyn and Grund, Jean-Paul Cornelius and Van Hout, Marie Claire and McVeigh, Jim (2016) A scoping review of home-produced heroin and amphetamine-type stimulant substitutes: implications for prevention, treatment, and policy. Harm Reduction Journal , 13 , (14) .

(2015) From Drugnet Europe. Drugnet Ireland , Issue 54, Summer 2015 , pp. 24-25.

Lindstrøm, Maia and Saidj, Madina and Kowalski, Krystyna and Filges, Trine and Rasmussen, Pernille Skovbo and Jørgensen, Anne-Marie Klint (2015) Family Behavior Therapy (FBT) for young prople in treatment for non-opioid drug use. A systematic review. Campbell Systematic Reviews , 11 , (1) , pp. 1-77.

McVeigh, T and Hynes, N and Tawfick, W and Sultan, S (2014) Endovascular aneurysm repair for multiple aneurysms as a sequel of hypereosinophilic syndrome. Vascular and endovascular surgery , 48 , (3) , pp. 277-280.

Nees, F and Fitzgerald, M (2014) Two cases of methaemoglobinaemia secondary to amyl nitrate use. Irish Medical Journal , 107 , (2) .

Killian, Lyndsey M and Docherty, James R (2014) Cardiovascular stimulant actions of bupropion in comparison to cocaine in the rat. European Journal of Pharmacology , 735 , pp. 32-7.

Galvin, Brian (2013) Monitoring centre report reveals latest drug trends in Europe. Drugnet Ireland , Issue 44, Winter 2012 , pp. 4-5.

Montanari, Linda and Pasinetti, Manuala and Guarita, Bruno and Royuela, Luis and Mulligan, Kobie and Vicente, Julian and Klempova, Danica and Pirona, Alessandro and Gyarmathy, Anna (2013) Stimulant use among clients entering drug treatment in Europe. Drugs: Education Prevention and Policy , 20 , (1) , pp. 48-55.

Vanattou-Saïfoudine, Natacha and McNamara, R and Harkin, A (2012) Caffeine provokes adverse interactions with 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') and related psychostimulants: mechanisms and mediators. British Journal of Pharmacology , 167 , (5) , pp. 946-959.

Lingford-Hughes, AR and Welch, S and Peters, L and Nutt, DJ (2012) BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP. Journal of Psychopharmacology , 26 , (7) , pp. 899-952.

Long, Jean and Horgan, Justine (2012) Drug use among the general population, by regional drugs task force area. Drugnet Ireland , Issue 43, Autumn 2012 , pp. 24-27.

Iqbal, M and Monaghan, Thomas S and Redmond, Janice (2012) Manganese toxicity with ephedrone abuse manifesting as parkinsonism: a case report. Journal of Medical Case Reports , 6 , (1) , p. 52.

Kavanagh, Pierce and Angelov, Daniel and O'Brien, John and Fox, John and O'Donnell, Cora and Christie, Rachel and Power, JD and McDermott, Sean (2011) The syntheses and characterization 3β-(4-fluorobenzoyloxy)tropane (fluorotropacocaine) and its 3α isomer. Drug Testing and Analysis , 4 , (1) , pp. 33-38.

Shoptaw, Steven J and Kao, Uyen and Ling, Walter (2009) Treatment for amphetamine psychosis. Cochrane Database of Systematic Reviews , (1) .

Decorte, Tom (2007) Problems, needs and service provision related to stimulant use in European prisons. International Journal of Prisoner Health , 3 , (1) , pp. 29-42.

Kavanagh, PV and Dunne, J and Feely, John and Maguire, Richard and Corrigan, Desmond and Keating, JJ and Meegan, MJ and Clancy, JM and Burdett, J (2001) Phenylalkylamine abuse among opiate addicts attending a methadone treatment programme in the Republic of Ireland. Addiction Biology , 6 , (2) , pp. 177-181.

Birchard, Karen (2000) Irish concerned about health effects of stimulant soft drinks. The Lancet , 356 , (9245) , p. 1911.

Report

Health Research Board. Irish National Focal Point to the European Monitoring Centre for Drugs and Drug Addiction. (2024) Ireland: national report for 2023 – drugs. Dublin: Health Research Board.

UNODC Prevention, Treatment and Rehabilitation Section. (2024) #ScaleUp. Scalable interventions for the treatment and care of stimulant use disorders. Vienna: United Nations Office on Drugs and Crime.

RADAR. (2023) RADAR A to Z: a guide to common drug names in Scotland. Edinburgh: Public Health Scotland.

Ontario Drug Policy Research Network, Public Health Ontario. (2023) Characteristics of substance-related toxicity deaths in Ontario. Stimulant, opioid, benzodiazepine, and alcohol-related deaths. Toronto: ODPRN.

Spencer, Merianne Rose and Miniño, Arialdi M and Garnett, Matthew F (2023) Co-involvement of opioids in drug overdose deaths involving cocaine and psychostimulants, 2011–2021. Hyattsville, MD: National Center for Health Statistics.

European Monitoring Centre for Drugs and Drug Addiction. (2023) European drug report 2023: trends and developments. Luxembourg: Publications Office of the European Union.

Substance Abuse and Mental Health Services Administration. (2023) Lesbian, gay, and bisexual behavioral health: results from the 2021 and 2022 National Surveys on Drug Use and Health. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration.

Chrzanowska, Agata and Man, Nicola and Akhurst, Jane and Sutherland, Rachel and Degenhardt, Louisa and Peacock, Amy (2023) Trends in overdose and other drug-induced deaths in Australia, 2002-2021. Sydney: National Drug and Alcohol Research Centre, UNSW Sydney.

Ireland. Revenue Commissioners. (2023) Revenue Commissioners annual report 2022. Dublin: Revenue Commissioners.

RADAR. (2022) A guide to common drug names in Scotland. Edinburgh: Public Health Scotland.

National Forensic Laboratory Information System. (2022) NFLIS-Drug 2021 annual report. U.S. Drug Enforcement Administration, Diversion Control Division.

Centre on Drug Policy Evaluation. (2022) What’s contaminating Toronto’s drug supply? insights from samples checked by Toronto’s drug checking service January 1 - December 31, 2021. Toronto: Centre on Drug Policy Evaluation.

European Monitoring Centre for Drugs and Drug Addiction. (2022) European drug report 2022: trends and developments. Luxembourg: Publications Office of the European Union.

Doyle, Anne and Sunday, Salome and Galvin, Brian and Mongan, Deirdre (2022) Alcohol and other drug use among children and young people in Ireland: prevalence, risk and protective factors, consequences, responses, and policies. Dublin: Health Research Board.

Krotulski, Alex J and Fogarty, Melissa F and Papsun, Donna M and Lamb, Michael and Walton, Sara E and Logan, Barry K (2022) Synthetic stimulant market rapidly changing as N,N-Dimethylpentylone replaces Eutylone in drug supply typically sold as “ecstasy” or “molly”. Pennsylvania: Center for Forensic Science Research & Education.

Substance Abuse and Mental Health Services Administration. (2021) Advisory: Prescription stimulant misuse among youth and young adults. Rockville, MD: National Mental Health and Substance Use Policy Laboratory. Substance Abuse and Mental Health Services Administration.

European Monitoring Centre for Drugs and Drug Addiction. (2021) Polydrug use: health and social responses. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2021) Stimulants: health and social responses. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Substance Abuse and Mental Health Services Administration. (2021) Treatment for stimulant use disorders. Rockville, MD: Substance Abuse and Mental Health Services Administration.

European Monitoring Centre for Drugs and Drug Addiction. (2021) European drug report 2021: trends and developments. Luxembourg: Publications Office of the European Union.

Rigoni, Rafaela and Liebregts, Nienke and Schiffer, Katrin (2021) Briefing paper. Treatment, prevention and harm reduction interventions for different forms of ATS use. Amsterdam: De Regenboog Groep; Correlation-European Harm Reduction Network.

Public Health England. (2021) Drug Harms Assessment and Response Team. Quarterly summary for professionals: May 2021. London: Public Health England.

Hedegaard, Holly and Miniño, Arialdi M and Warner, Margaret (2021) Co-involvement of opioids in drug overdose deaths involving cocaine and psychostimulants. Hyattsville, MD: National Center for Health Statistics.

Toronto's Drug Checking Service. (2021) What's in Toronto's drug supply? Results from samples checked by Toronto's drug checking service January 1 - December 31, 2020. Toronto: Centre on Drug Policy Evaluation.

Davies, Miranda and Keeble, Eilís and Hutchings, Rachel (2021) Injustice? Towards a better understanding of health care access challenges for prisoners. London: Nuffield Trust.

Quinlan, Mick and McCartney, Daniel (2020) EMIS-2017. Ireland community report - part three: key findings for the 142 HIV diagnosed respondents in Ireland. Dublin: Gay Health Network.

Quinlan, Mick and McCartney, Daniel (2020) EMIS-2017. Ireland community report - part four: key findings for the 514 respondents not born in the republic of Ireland. Dublin: Gay Health Network.

European Monitoring Centre for Drugs and Drug Addiction. Mansfield, David (2020) Emerging evidence of Afghanistan’s role as a producer and supplier of ephedrine and methamphetamine. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2020) European drug report 2020: key issues summary. Luxembourg: Publications Office of the European Union.

Peacock, Amy and Price, Olivia and Dietze, Paul and Bruno, Raimondo and Salom, Caroline and Lenton, Simon R and Swanton, Rosie and Uporova, Julia and Karlsson, A and Chan, Roanna and Gibbs, Daisy and Grigg, Jodie and Daly, Catherine and Hall, Cristal and Wilson, Tanya and Degenhardt, Louisa and Farrell, Michael (2020) Impacts of COVID-19 and associated restrictions on people who use illicit stimulants in Australia: findings from the Ecstasy and Related Drugs Reporting System 2020. Sydney: National Drug and Alcohol Research Centre.

European Monitoring Centre for Drugs and Drug Addiction. (2020) European drug report 2020: trends and developments. Luxembourg: Publications Office of the European Union.

Substance Abuse and Mental Health Services Administration. (2020) Treatment of stimulant use disorders. Rockville, MD: National Mental Health and Substance Use Policy Laboratory. Substance Abuse and Mental Health Services Administration.

Dong, K and Meador, Karine and Hyshka, E and Salokangas, E and Burton-MacLeod, S and Bablitz, C and Lail, P and Colizza, K and Etches, N and Cardinal, C and Twan, S and Gilani, F and Brooks, HL and Wild, TC (2020) Supporting people who use substances in acute care settings during the COVID-19 pandemic: CRISM – interim guidance document. Edmonton, Alberta: Canadian Research Initiative in Substance Misuse.

Drug Enforcement Administration, U.S. Department of Justice. (2020) Drugs of abuse: a DEA resource guide. Washington DC: Drug Enforcement Administration, U.S. Department of Justice.

European Monitoring Centre for Drugs and Drug Addiction. (2019) Estimating the size of the main illicit retail drug markets in Europe: an update. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2019) Drug precursor developments in the European Union. Luxembourg: Publications Office of the European Union.

The EMIS Network. (2019) EMIS-2017. The European men-who-have-sex-with-men internet survey: key findings from 50 countries. Stockholm: European Centre for Disease Prevention and Control.

Kelly, Georgia and Bruno, Raimondo and Peacock, Amy (2019) Recent use of ‘capsules contents unknown’ among a sample of people who frequently use ecstasy and other illicit stimulants in Australia. Sydney: National Drug and Alcohol Research Centre.

United Nations Office on Drugs and Crime. (2019) Treatment of stimulant use disorders: current practices and promising perspectives. Vienna: United Nations Office on Drugs and Crime.

International Network of People who Use Drugs. (2019) Chemsex: a case study of drug-userphobia. London: INPUD.

European Monitoring Centre for Drugs and Drug Addiction. (2018) Captagon: understanding today's illicit market. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2017) Drugs and the darknet: perspectives for enforcement, research and policy. Luxembourg: Publications Office of the European Union.

Mentor, Adfam. (2017) Talking to your children about new psychoactive substances and club drugs. A handbook for parents and carers. London: Mentor and Adfam.

National Advisory Committee on Drugs and Alcohol, Northern Ireland. Department of Health. (2017) Prevalence of drug use and gambling in Ireland and drug use in Northern Ireland 2014/15: regional drug and alcohol task force (Ireland) and health and social care trust (Northern Ireland) results. Bulletin 2. Dublin: Department of Health.

European Monitoring Centre for Drugs and Drug Addiction. (2017) High-risk drug use and new psychoactive substances. Luxembourg: Publications Office of the European Union.

Health Research Board. (2016) National Drug-Related Deaths Index 2004 to 2014 data. Dublin: Health Research Board.

Leslie, Ellen and Smirnov, Andrew and Najman, Jake M and Scott, John (2016) Alcohol use and motivations for drinking among types of young adult illicit stimulant users. Canberra: Australian Institute of Criminology.

National Advisory Committee on Drugs and Alcohol, Northern Ireland. Department of Health. (2016) Prevalence of drug use and gambling in Ireland & drug use in Northern Ireland. Bulletin 1. Dublin: National Advisory Committee on Drugs and Alcohol.

United Nations Office on Drugs and Crime. (2016) Terminology and information on drugs. New York: United Nations.

Center for Substance Abuse Treatment. (2016) Matrix intensive outpatient treatment for people with stimulant use disorders: counselor's family education. Rockville, MD: Substance Abuse and Mental Health Services Administration.

Center for Substance Abuse Treatment. (2015) Matrix intensive outpatient treatment for people with stimulant use disorders: client's treatment companion. Rockville, MD: Substance Abuse and Mental Health Services Administration.

Pinkham, Sophie and Stone, Katie (2015) A global review of the harm reduction response to amphetamines: a 2015 update. London: Harm Reduction International.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2015) EMCDDA–Europol joint report on a new psychoactive substance: 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone (α-PVP). Luxembourg: Publications Office of the European Union.

Novel Psychoactive Treatment UK Network. Abdulrahim, D and Bowden-Jones, O (2015) Guidance on the clinical management of acute and chronic harms of club drugs and novel psychoactive substances. London: NEPTUNE.

Jennings, Ciaran J and Patten, Emer and Kennedy, Mark and Kelly, Chris (2014) Examining the profile and perspectives of individuals attending harm reduction services who are users of performance and image enhancing drugs. Dublin: Merchants Quay Ireland.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Report on the risk assessment of 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone in the framework of the Council Decision on new psychoactive substances. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Report on the risk assessment of 1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one in the framework of the Council Decision on new psychoactive substances. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Report on the risk assessment of 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine in the framework of the Council Decision on new psychoactive substances. Luxembourg: Office for Official Publications of the European Communities.

Drummond, Anne and Codd, Mary (2014) Drugs and health in Irish prisons 2011. A report for prisoners. National Advisory Committee on Drugs and Alcohol.

Center for Substance Abuse Treatment. (2013) Matrix intensive outpatient treatment for people with stimulant use disorders: counselor's treatment manual. Rockville, MD: Substance Abuse and Mental Health Services Administration.

Trautmann, Franz and Kilmer, Beau and Turnbull, Paul J (2013) Further insights into aspects of the EU illicit drugs market: summaries and key findings. Luxembourg: Publications Office of the European Union.

Irish Sports Council. (2013) Irish Sports Council anti-doping testing 2012. Dublin: Irish Sports Council.

Pilling, Stephen and Hardy, Robert (2013) Review of the Dublin North City and County addiction service. Dublin: Psychological Interventions Research Centre and University College London.

Medicines and Healthcare products Regulatory Agency. (2012) Pseudoephedrine- and ephedrine-containing medicines: 2012 review of actions to manage the risk of misuse. MHRA UK public assessment report. London: MHRA.

Center for Substance Abuse Treatment. (2012) Using Matrix with women clients. A supplement to the Matrix intensive outpatient treatment for people with stimulant use disorders. Rockville, MD: Substance Abuse and Mental Health Services.

European Monitoring Centre for Drugs and Drug Addiction. (2012) EMCDDA-Europol joint report on a new psychoactive substance: 4-methylamphetamine. Luxembourg: Publications Office of the European Union.

Ventura, Mireia and Noijen, Judith and Bücheli, Alexander and Isvy, Alexandre and van Huyck, Catherine and Martins, Daniel and Nagy, Constanze and Schipper, Vivian and Ugarte, Miren and Valente, Helena (2012) Drug checking service: good practice standards. Brussels: Nightlife Empowerment & Well-Being Implementation Project.

United Nations Office on Drugs and Crime. (2011) Global SMART update 2011. Volume 6. Vienna: United Nations Office on Drugs and Crime.

International Narcotics Control Board. (2011) Report of the International Narcotics Control Board on the availability of internationally controlled drugs: ensuring adequate access for medical and scientific purposes. New York: United Nations.

World Health Organization, Western Pacific Region. (2011) Technical briefs on amphetamine-type stimulants (ATS). Philippenes: World Health Organization, Western Pacific Region.

Centre for Public Health, Liverpool John Moores University. (2011) A summary of the health harms of drugs. London: Department of Health & National Treatment Agency for Substance Misuse.

European Monitoring Centre for Drugs and Drug Addiction. (2011) Annual report 2011: the state of the drugs problem in Europe. Luxembourg: Publications Office of the European Union.

United Nations Office on Drugs and Crime. (2010) Global SMART update 2010. Volume 4. Vienna: United Nations Office on Drugs and Crime.

Advisory Council on the Misuse of Drugs. (2010) Consideration of the naphthylpyrovalerone analogues and related compounds. London: Home Office.

Sykes, Wendy and Coleman, Nick and Desai, Philly and Groom, Carola and Gure, Mohamud and Howarth, Radhika (2010) Perceptions of the social harms associated with khat use. London: Home Office.

European Monitoring Centre for Drugs and Drug Addiction. (2010) Annual report 2010: the state of the drugs problem in Europe. Luxembourg: Publications Office of the European Union.

O'Colmain, Aidan (2010) Drugs and doping in sport - guidelines for general practitioners. Dublin: Irish College of General Practitioners and Irish Sports Council.

Kenny, Pauline and Swan, Amy and Berends, Lynda and Jenner, Linda and Hunter, Barbara and Mugavin, Janette (2009) Alcohol and other drug withdrawal: practice guidelines. Victoria: Turning Point Alcohol and Drug Centre.

National Institute for Health and Clinical Excellence. (2007) Drug misuse in over 16s: psychosocial interventions. London: NICE.

Baker, A. and Kay-Lambkin, Frances and Lee, NK and Claire, M and Jenner, Linda (2003) A brief cognitive behavioural intervention for regular amphetamine users. A treatment guide. Canberra: Australian Government Department of Health and Ageing.

Scottish Executive. Substance Misuse Division. Effective Interventions Unit. (2002) Psychostimulants: a practical guide. Edinburgh: Substance Misuse Division, Scottish Executive.

World Health Organization. (1989) WHO expert committee on drug dependence. Twenty-fifth report. Geneva: World Health Organization.

Webpage

European Monitoring Centre for Drugs and Drug Addiction. (2023) Spotlight on… Addressing sexual health issues associated with drug use. URL: https://www.emcdda.europa.eu/spotlights/addressing...

European Monitoring Centre for Drugs and Drug Addiction. (2023) Health and social responses to drug problems: a European guide 2021. URL: https://www.emcdda.europa.eu/publications/health-a...

National Drug and Alcohol Research Centre. (2023) The Ecstasy and Related Drugs Reporting System (EDRS). URL: https://ndarc.med.unsw.edu.au/project/ecstasy-and-...

National Centre for Education and Training on Addiction. (2021) Standardised alcohol & other drug (AOD) screening & withdrawal tools. URL: https://aodscreening.flinders.edu.au/about-collect...

Drugs.ie. (2018) GHB - G information resources. URL: http://drugs.ie/ghb

Ana Liffey Drug Project, Dublin Institute of Technology, Trinity College Dublin, University College Dublin. (2016) What’s in the powder? URL: http://www.drugs.ie/whatsinthepowder

FactSheet

Public Health England. (2021) ASSIST-Lite screening tool: how to use.

Substance Abuse and Mental Health Services Administration. (2020) Tips for teens: the truth about hallucinogens, sedatives and prescription stimulants. Rockville, MD: Substance Abuse and Mental Health Services Administration.

Be Smart. Be Safe.. (2019) Home truths. Are you aware of the drugs that are all around us? Dublin: Be Smart. Be Safe.

Dail Debates

[Oireachtas] Dail Eireann debate. Written answer 389 - Prescriptions data [22891/17]. (16 May 2017)

[Oireachtas] Dail Eireann debate. Written answer 196 - Misuse of drugs [Whack] [28766/10]. (05 Oct 2010)

Book

National Drug and Alcohol Research Centre. (2017) Quick guide to drugs & alcohol. New South Wales: Drug Info. State Library of NSW .

Shapiro, Harry (2010) The media guide to drugs: key facts and figures for journalists. London: Drugscope .

Conference or Workshop Item

Darke, Shane (2020) Deaths due to new psychoactive stimulants. In: 2020 NDARC Seminar Series, 27 February 2020.

Broderick, Gary (2010) The impact of stimulants on women in recovery: a qualitative review of female clients from North Inner City Dublin. In: Conference on stimulant abuse treatment, 10-12 May 2010, Strasbourg.

Video

European Monitoring Centre for Drugs and Drug Addiction. (2023) EMCDDA webinar: Responding to stimulant use — developments in treatment. EMCDDA.

Audio

Henry, Karl (2021) Real Health Podcast: the cocaine episode.

Dataset

Health Research Board. (2021) National Drug and Alcohol Survey [Ireland].

News

Health Products Regulatory Authority. [HPRA] Close to 900,000 units of illegal medicines detained by the HPRA in 2023. (28 Mar 2024)

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] World AIDS Day: concerns over stimulant injecting and late HIV diagnoses in Europe. (30 Nov 2023)

[thejournal.ie] , Deegan, Gordon 25-year-old man died after taking little known synthetic drug in Clare pub. (27 Mar 2018)

[Independent.ie] , Walsh, Orla The truth about energy drinks. (13 Mar 2018)

[Irish Times] , McGuire, Peter ‘Chemsex’ drug raises concern about health and consent. (05 Jan 2017)

[drugs.ie] Sexual health and addiction services launch ‘G’ harm reduction resources. (19 Dec 2016)

[Health Research Board] Health Research Board publish latest drug-related deaths figures. (13 Dec 2016)

[Irish Examiner] New trend called 'chemsex' causing sharp rise in STIs in Dublin. (13 Dec 2016)

[Irish Examiner] , McCarthaigh, Sean New drug ‘snow blow’ linked to four deaths in Ireland. (28 Sep 2015)

[thejournal.ie] , Duffy, Ronan How often do people use drugs while working? Most often around exam time anyway. (09 Jun 2015)

[thejournal.ie] , Winstock, Adam and Maier, Larissa Opinion: Academic doping – can drugs make you smarter? (22 Nov 2014)

[thejournal.ie] , Hennessy, Michelle Irish watchdog likely to recommend that energy drinks are not consumed by children. (30 Oct 2014)

[Irish Mirror] , Ward, James Warning as deadly designer drug MDPV hits streets. (19 Sep 2014)

[Health Research Board] New report reveals the latest drug trends in Europe: HRB compares situation in Ireland with European findings. (27 May 2014)

[Health Service Executive] HSE alert on deaths from stimulants. (22 May 2014)

[rte.ie] HSE in warning to drug users over powder form of ecstasy. (12 Sep 2012)

[thejournal.ie] 50,000 illegal and counterfeit medicines seized in Ireland. (30 Sep 2011)

European Monitoring Centre for Drugs and Drug Addiction. [European Monitoring Centre for Drugs and Drug Addiction] Europe faces new challenges posed by changes in drug supply and use. (10 Nov 2010)

[Department of Health and Children] Opening statement for meeting of Joint Committee on Health and Children in relation to recent legislation made to control certain substances under the Misuse of Drugs Act 1977. (01 Jun 2010)